Can I focus on treating vulvar leukoplakia?

Vulvar leukoplakia is a common gynecological disease in clinical practice. Its common treatment method is focused ultrasound therapy, which utilizes the mechanical, cavitation, thermal effects and functional adjustment effects of ultrasound to destroy diseased tissues and achieve therapeutic effects. It is introduced below.

This method for treating vulvar leukoplakia has the advantages of being safe, non-invasive, effective, easy to recover, with few complications and leaving no scars.

In the past, leukoplakia vulvae was mostly treated surgically, in which the whitened skin of the vulva was removed. Surgical treatment not only increases the pain for patients, but also has a high recurrence rate. Statistics show that the recurrence rate of surgical treatment of vulvar leukoplakia is 45% to 50% during a follow-up observation period of 3 to 15 years after surgery, which means that about half of the cases will relapse. In recent years, a new "HIFU" technology has emerged internationally, filling the gap in the medical field. The HIFU technology, with its unique "inside-out" new model, has created a new era of minimally invasive treatment of vulvar leukoplakia and cervical diseases.

This technology has the advantages of being non-invasive, efficient, safe, non-radioactive, well controllable, and allowing for rapid recovery after treatment. It has unique therapeutic effects on vulvar white lesions, chronic cervicitis, and vulvar pruritus. It has become a new method for the treatment of vulvar skin diseases. It can eliminate lesions and restore the tissue to normal without changing the anatomical structure of the tissue.